Delving into the Latest Updates on Rukeshu Capsule with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Other Diseases

Active Indication

Breast hyperplasia

Inactive Indication-

Originator Organization

Shaanxi Licai Pharmaceutical Co Ltd.

Active Organization

Shaanxi Licai Pharmaceutical Co Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

1. To further evaluate the effectiveness of Rukeshu capsule in treating breast hyperplasia (liver depression and phlegm stagnation, Chong and Ren meridians disorder syndrome). 2. To provide a basis for determining the dosage for Phase III clinical trials; 3. To evaluate the safety of Rukeshu capsule.

Start Date12 Nov 2014

Sponsor / Collaborator

Shaanxi Licai Pharmaceutical Co Ltd.

CTR20130114

/ CompletedPhase 2

乳可舒胶囊剂量探索与安慰剂对照治疗乳腺增生（肝郁痰凝、冲任失调证）

[Translation] Dose exploration of Rukeshu capsules and placebo control in the treatment of breast hyperplasia (liver depression and phlegm stagnation, Chong and Ren disorders)

1. 初步评价乳可舒胶囊治疗乳腺增生（肝郁痰凝、冲任失调证）的有效性。 2. 为确定Ⅲ期临床试验的给药剂量提供依据。 3. 评价乳可舒胶囊的安全性。

[Translation]

1. To preliminarily evaluate the effectiveness of Rukeshu Capsules in treating breast hyperplasia (liver depression and phlegm stagnation, Chong and Ren meridians disorder syndrome). 2. To provide a basis for determining the dosage for Phase III clinical trials. 3. To evaluate the safety of Rukeshu Capsules.

Start Date17 Aug 2012

Sponsor / Collaborator

Shaanxi Licai Pharmaceutical Co Ltd.

100 Clinical Results associated with Rukeshu Capsule

Login to view more data

100 Translational Medicine associated with Rukeshu Capsule

Login to view more data

100 Patents (Medical) associated with Rukeshu Capsule

Login to view more data

100 Deals associated with Rukeshu Capsule

Login to view more data